Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 17 04:00PM ET
508.86
Dollar change
-13.82
Percentage change
-2.64
%
IndexNDX, S&P 500 P/E12.95 EPS (ttm)39.29 Insider Own3.61% Shs Outstand106.40M Perf Week-2.80%
Market Cap54.94B Forward P/E12.85 EPS next Y39.59 Insider Trans0.00% Shs Float104.06M Perf Month-14.38%
Income4.50B PEG9.52 EPS next Q8.57 Inst Own87.17% Short Float2.59% Perf Quarter-23.48%
Sales14.09B P/S3.90 EPS this Y-21.68% Inst Trans0.98% Short Ratio2.04 Perf Half Y-31.33%
Book/sh271.60 P/B1.87 EPS next Y10.80% ROA12.51% Short Interest2.70M Perf Year-50.43%
Cash/sh77.33 P/C6.58 EPS next 5Y1.36% ROE15.96% 52W Range476.49 - 1211.20 Perf YTD-28.56%
Dividend Est.2.83 (0.56%) P/FCF17.71 EPS past 5Y15.74% ROIC14.02% 52W High-57.99% Beta0.31
Dividend TTM1.76 (0.35%) Quick Ratio4.03 Sales past 5Y16.71% Gross Margin82.28% 52W Low6.79% ATR (14)20.93
Dividend Ex-DateMay 20, 2025 Current Ratio4.93 EPS Y/Y TTM15.65% Oper. Margin28.11% RSI (14)40.52 Volatility1.84% 5.15%
Employees15106 Debt/Eq0.09 Sales Y/Y TTM7.52% Profit Margin31.94% Recom1.67 Target Price726.00
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q15.94% Payout0.00% Rel Volume0.67 Prev Close522.68
Sales Surprise-6.74% EPS Surprise-4.66% Sales Q/Q-3.70% EarningsApr 29 BMO Avg Volume1.32M Price508.86
SMA20-5.57% SMA50-9.24% SMA200-32.25% Trades Volume889,813 Change-2.64%
Date Action Analyst Rating Change Price Target Change
May-30-25Downgrade Wells Fargo Overweight → Equal Weight $580
May-30-25Downgrade RBC Capital Mkts Outperform → Sector Perform $662
May-14-25Upgrade Citigroup Neutral → Buy $700
Apr-22-25Resumed Cantor Fitzgerald Overweight $695
Feb-05-25Upgrade Leerink Partners Market Perform → Outperform $762 → $834
Jan-16-25Downgrade UBS Buy → Neutral $1130 → $738
Dec-10-24Resumed BofA Securities Underperform $565
Nov-15-24Initiated Wolfe Research Outperform $1150
Nov-14-24Initiated Citigroup Neutral $895
Sep-24-24Downgrade Leerink Partners Outperform → Market Perform $1175 → $1077
Today 07:14AM
05:44AM
04:00AM
04:00AM
Jun-16-25 05:22PM
01:24PM Loading…
01:24PM
07:23AM
06:36AM
Jun-15-25 11:21AM
09:59AM
05:38AM
Jun-14-25 05:46PM
09:55AM
Jun-13-25 04:30PM
04:22PM
04:14PM Loading…
04:14PM
08:57AM
Jun-12-25 07:00PM
12:25PM
11:05AM
10:00AM
Jun-11-25 08:01PM
02:01PM
10:10AM
09:10AM
Jun-10-25 02:56PM
11:24AM
04:23AM
Jun-09-25 11:35PM
11:00AM
10:30AM Loading…
10:30AM
08:44AM
06:00AM
Jun-07-25 06:30PM
Jun-06-25 01:27PM
09:12AM
Jun-05-25 04:16PM
04:06PM
10:18AM
08:45AM
Jun-04-25 09:41PM
07:13PM
05:16AM
Jun-03-25 08:18PM
09:05AM
04:52AM
Jun-02-25 10:29AM
07:56AM
07:45AM
07:44AM
07:05AM
07:00AM
06:41AM
05:11AM
04:45AM
May-31-25 08:04AM
May-30-25 06:22PM
05:12PM
04:23PM
12:46PM
12:07PM
11:59AM
10:31AM
10:20AM
10:19AM
10:11AM
09:01AM
08:30AM
06:37AM
06:34AM
04:25AM
03:19AM
01:00AM
May-29-25 03:35PM
10:04AM
05:30AM
12:32AM
May-24-25 05:31AM
May-23-25 05:10PM
04:09PM
04:02PM
10:01AM
06:19AM
03:00AM
May-22-25 05:00PM
10:18AM
May-21-25 10:51AM
05:45AM
May-20-25 05:06PM
12:12PM
11:35AM
09:11AM
07:30AM
06:48AM
04:59AM
May-19-25 04:42PM
03:29PM
02:30PM
01:52PM
12:42PM
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SING GEORGE LDirectorDec 31 '24Option Exercise413.333,3381,379,69629,610Jan 03 04:02 PM
McCourt MarionEVP CommercialNov 01 '24Option Exercise381.401,000381,40013,931Nov 05 04:23 PM
McCourt MarionEVP CommercialNov 01 '24Sale844.611,000844,61012,931Nov 05 04:23 PM
MARION E MCCOURTOfficerNov 01 '24Proposed Sale844.611,000844,610Nov 01 04:38 PM
RYAN ARTHUR FDirectorOct 01 '24Sale1048.78100104,87817,582Oct 03 04:02 PM
McCourt MarionEVP CommercialOct 01 '24Option Exercise381.401,000381,40013,931Oct 03 04:02 PM
McCourt MarionEVP CommercialOct 01 '24Sale1054.061,0001,054,06012,931Oct 03 04:02 PM
MARION E MCCOURTOfficerOct 01 '24Proposed Sale1054.061,0001,054,060Oct 01 04:13 PM
McCourt MarionEVP CommercialSep 03 '24Option Exercise381.401,000381,40013,931Sep 05 04:01 PM
McCourt MarionEVP CommercialSep 03 '24Sale1178.731,0001,178,73012,931Sep 05 04:01 PM
RYAN ARTHUR FDirectorSep 03 '24Sale1178.68100117,86817,682Sep 05 04:01 PM
MARION E MCCOURTOfficerSep 03 '24Proposed Sale1178.731,0001,178,730Sep 03 04:04 PM
Fenimore Christopher R.SVP Finance & CFOAug 28 '24Sale1205.335,6806,846,2620Aug 29 04:27 PM
Christopher FenimoreOfficerAug 28 '24Proposed Sale1205.215,6806,845,565Aug 28 04:35 PM
Bassler Bonnie LDirectorAug 15 '24Option Exercise371.40756280,7782,138Aug 19 04:02 PM
Bassler Bonnie LDirectorAug 15 '24Sale1170.00756884,5201,382Aug 19 04:02 PM
POON CHRISTINE ADirectorAug 15 '24Option Exercise413.3310,8384,479,67113,010Aug 19 04:01 PM
POON CHRISTINE ADirectorAug 15 '24Sale1158.1710,83812,552,2842,172Aug 19 04:01 PM
Christine PoonDirectorAug 15 '24Proposed Sale1156.8610,83812,538,049Aug 15 05:55 PM
MURPHY ANDREW JEVP ResearchAug 13 '24Option Exercise399.6620,0007,993,20068,306Aug 15 04:01 PM
MURPHY ANDREW JEVP ResearchAug 14 '24Sale1153.156,3637,337,50548,306Aug 15 04:01 PM
Bassler Bonnie LDirectorAug 15 '24Proposed Sale1170.00756884,520Aug 15 11:45 AM
MURPHY ANDREW JOfficerAug 14 '24Proposed Sale1152.276,3637,331,894Aug 14 04:08 PM
STAHL NEILEVP Research and DevelopmentAug 08 '24Sale1084.545,1975,636,34650,999Aug 12 04:05 PM
Neil StahlOfficerAug 08 '24Proposed Sale1084.465,1975,635,926Aug 08 04:53 PM
Pitofsky JasonVP ControllerAug 07 '24Option Exercise372.46487181,3884,691Aug 07 04:40 PM
Pitofsky JasonVP ControllerAug 07 '24Sale1070.00487521,0904,204Aug 07 04:40 PM
Jason PitofskyOfficerAug 07 '24Proposed Sale1069.75487520,970Aug 07 04:33 PM
STAHL NEILEVP Research and DevelopmentAug 02 '24Option Exercise555.6723,63813,134,92774,637Aug 06 04:03 PM
Bassler Bonnie LDirectorAug 02 '24Option Exercise371.40756280,7782,138Aug 05 04:05 PM
Bassler Bonnie LDirectorAug 02 '24Sale1115.00756842,9401,382Aug 05 04:05 PM
McCourt MarionEVP CommercialAug 01 '24Option Exercise372.461,137423,48714,068Aug 05 04:04 PM
McCourt MarionEVP CommercialAug 01 '24Sale1060.861,1371,206,19812,931Aug 05 04:04 PM
RYAN ARTHUR FDirectorAug 01 '24Sale1100.0311,10017,782Aug 05 04:01 PM
RYAN ARTHUR FDirectorAug 01 '24Sale1085.5399107,46717,783Aug 05 04:01 PM
Bassler Bonnie LDirectorAug 02 '24Proposed Sale1115.00756842,940Aug 02 10:43 AM
MARION E MCCOURTOfficerAug 01 '24Proposed Sale1060.861,1371,206,198Aug 01 04:18 PM
Arthur F. RyanDirectorAug 01 '24Proposed Sale1079.19300323,757Aug 01 04:02 PM
LAROSA JOSEPH JEVP General Counsel and SecretJul 11 '24Sale1088.951,8662,031,98137,937Jul 12 04:00 PM
McCourt MarionEVP CommercialJul 01 '24Option Exercise372.461,137423,48714,068Jul 02 04:01 PM
McCourt MarionEVP CommercialJul 01 '24Sale1047.111,1371,190,56412,931Jul 02 04:01 PM
RYAN ARTHUR FDirectorJul 01 '24Sale1059.24100105,92417,882Jul 02 04:01 PM
Bassler Bonnie LDirectorJun 24 '24Option Exercise371.40756280,7782,138Jun 25 04:41 PM
Bassler Bonnie LDirectorJun 24 '24Sale1062.00756802,8721,382Jun 25 04:41 PM
LAROSA JOSEPH JEVP General Counsel and SecretJun 24 '24Option Exercise555.6714,4508,029,43150,887Jun 25 04:39 PM